GlassScriptPhysician profile
Ramez S Nairooz
NPI 1750710810
$7,862.97
in general payments reported to CMS, 2019-2025
39 companies · $804 in 2025
The $804 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,995 · 2020: $1,203 · 2021: $385 · 2022: $126 · 2023: $636 · 2024: $714 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,154.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,812.52 | 2019-2021 | |
| Terumo Medical Corporation | $1,008.68 | 2019 | |
| Medtronic Vascular, INC. | $941.79 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $878.11 | 2019-2025 | |
| Boston Scientific Corporation | $702.55 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $595.68 | 2019-2025 | Lifevest |
| Inari Medical, INC. | $195.75 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Actelion Pharmaceuticals US, INC. | $151.80 | 2019-2020 | |
| Stryker Corporation | $134.08 | 2025 | Artix Mt |
| Chiesi USA, INC. | $133.46 | 2019 | |
| Pfizer INC. | $110.07 | 2021-2025 | |
| Abiomed | $95.97 | 2024-2025 | Impella |
| Inspire Medical Systems, INC. | $83.41 | 2023-2025 | Inspire |
| Irhythm Technologies, INC. | $81.98 | 2021 | |
| Amgen INC. | $81.40 | 2019-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $63.16 | 2021-2023 | Onyx Frontier |
| Penumbra, INC. | $62.28 | 2024 | Indigo System |
| Janssen Pharmaceuticals, INC | $61.60 | 2021-2024 | Xarelto |
| Atricure, INC. | $56.11 | 2024-2025 | Atriclip Laa Exclusion System |
| Alnylam Pharmaceuticals INC. | $51.80 | 2023 | Onpattro |
| Acist Medical Systems, INC. | $49.79 | 2023-2024 | |
| Lexicon Pharmaceuticals, INC. | $48.82 | 2023-2024 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $48.78 | 2022-2025 | Camzyos |
| Amicus Therapeutics, INC. | $46.40 | 2023 | Galafold |
| Daiichi Sankyo INC. | $45.82 | 2025 | Injectafer |
| Cvrx, INC. | $41.60 | 2022-2023 | Barostim Neo System |
| Scpharmaceuticals INC. | $37.62 | 2023-2025 | |
| Esperion Therapeutics, INC. | $31.97 | 2025 | Nexletol |
| Lantheus Medical Imaging, INC. | $23.72 | 2020 | |
| Philips North America LLC | $23.34 | 2021 | |
| Sumitomo Pharma America, INC. | $22.96 | 2025 | Gemtesa |
| Kiniksa Pharmaceuticals International, Plc | $22.36 | 2024 | Arcalyst |
| Solventum Corporation | $22.21 | 2024 | Activ.A.C., 3m Coban, Promogran Prisma |
| Altathera Pharmaceuticals LLC | $20.95 | 2025 | Sotalol Hydrochloride |
| Novo Nordisk INC | $16.40 | 2023 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $16.12 | 2024 | Winrevair |
| Heartflow, INC. | $15.30 | 2025 | |
| Itamar Medical INC | $14.73 | 2023 | Watchpatone |
| Cardiovascular Systems INC. | $11.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramez Nairooz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.